Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

Those market dynamics will again be in focus when Novo reports results for its diabetes drug Ozempic and weight-loss ... get ...

Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Online health platforms continue to advertise access to copycat versions of blockbuster weight-loss drugs Wegovy and Zepbound ...

Last month, Novo Nordisk asked the U.S. FDA to ban compounding pharmacies from making copycat versions of Wegovy and Ozempic, which it said were too complex for those manufacturers to produce safely.

Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...